• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

lombardmedical

Relievant Medsystems taps ex-Cameron Health chief Hykes for CEO | Personnel Moves, Sept. 26, 2017

September 26, 2017 By Brad Perriello

Relievant Medsystems said it named former Cameron Medical chief Kevin Hykes to be its new CEO, effective immediately. Hykes, who led Cameron Health to a $1.35 billion buyout in 2012 by Boston Scientific (NYSE:BSX), replaced Alex DiNello, who was named COO, Relievant said. Relievant makes the Intracept device for treating lower back pain. Hykes was most recently […]

Filed Under: Wall Street Beat Tagged With: Breathtec Biomedical Inc, Histogenics, HistoSonics Inc., integer, lombardmedical, Masimo, Medizone, pulmodyne, Relievant Medsystems Inc., RTI Surgical

Lombard touts expected 50% cost reduction in restructuring effort

September 14, 2017 By Fink Densford

Lombard Medical Technologies (NSDQ:EVAR) said today it completed a restructuring of its business after implementing a plan to focus its sales efforts on the UK, Japan and China, as well as reducing operating and manufacturing costs as it seeks to breakeven with its cash flow. The UK-based company said that the restructuring is expected to result […]

Filed Under: Business/Financial News Tagged With: lombardmedical, MicroPort Scientific

7 medtech stories we missed this week: May 19, 2017

May 19, 2017 By Danielle Kirsh

From FDA clearances to touting study data, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. XpandOrtho wins FDA 510(k) clearance XpandOrtho announced in a May 17 press release that it has received FDA 510(k) clearance for its electronic soft tissue balancing instrument for total knee replacement surgery. […]

Filed Under: 510(k), Clinical Trials, Food & Drug Administration (FDA), Regulatory/Compliance, Research & Development Tagged With: Body Vision Medical, Exactech Inc., lombardmedical, MedTech, NxThera Inc., Rivanna Medical, Visionsense, XpandOrtho

Lombard Medical CEO Hubbert, CFO Kullback step down | Personnel Moves, April 28, 2017

April 28, 2017 By Fink Densford

Lombard Medical Technologies (NSDQ:EVAR) said this month that its CEO Simon Hubbert and CFO William Kullback are stepping down from their positions, with Kurt Lemvigh stepping into the CEO role. Hubbert served as CEO for 6 years after joining the company in 2010, and will be replaced by Lemvigh, who has held positions with multiple companies, including […]

Filed Under: Business/Financial News Tagged With: Accuray Inc., becton dickinson, Boston Scientific, Cardiac Sciences Corp., ConMed Corp., Fresenius, GE Healthcare, lombardmedical, Magnolia Medical Technologies, ReWalk Robotics, Senseonics, Toshiba

Trumpcare’s prospects dim, but not too dim to hit stent graft makers

April 5, 2017 By Brad Perriello

The push on Capitol Hill to revive Trumpcare stalled yesterday, but not before the chatter out of Washington instigated a slide for stent graft makers’ stocks. The Affordable Care Act covers a 1-time screening for abdominal aortic aneurysms in men who smoke or smoked in the past, listing the test as an “essential health benefit.” The […]

Filed Under: Healthcare Reform, Stent Grafts, Wall Street Beat Tagged With: C.R. Bard, Capitol Hill, Endologix, lombardmedical

Lombard, MicroPort finalize strategic partnership

April 3, 2017 By Fink Densford

Lombard Medical Technologies (NSDQ:EVAR) said today it finalized a strategic partnership deal with MicroPort Scientific. Through the partnership, MicroPort will manufacture certain components for Lombard’s Aorfix and Altura product lines at its Shanghai facilities, slated to begin in the 2nd half of this year. “This strategic partnership begins to establish the foundation for improved gross margins […]

Filed Under: Business/Financial News, Vascular Tagged With: lombardmedical, MicroPort Scientific

Lombard wins Japanese clearance for IntelliFlex LP delivery device for Aorfix stent graft

January 5, 2017 By Fink Densford

Lombard Medical Technologies (NSDQ:EVAR) said today it won approval from the Japanese Ministry of Health, Labour and Welfare for its Intelliflex low profile delivery system for the Aorfix endovascular stent graft. The Oxfordshire, England-based company said it will initiate a commercial launch of the device in Japan once it receives reimbursement approval, expected some time next month. […]

Filed Under: Catheters, Regulatory/Compliance, Vascular Tagged With: lombardmedical

China’s Microport puts $15m into Lombard Medical

December 19, 2016 By Fink Densford

Lombard Medical Technologies (NSDQ:EVAR) said today that China’s MicroPort Orthopedics invested $15 million as part of a partnership deal between the 2 companies. Through the partnership, Lombard will seek to accelerate commercialization of its Aorfix and Altura stent grafts for treating abdominal aortic aneurysms. Microport will gain exclusive marketing rights for both products in China and Brazil, as […]

Filed Under: Mergers & Acquisitions, Stent Grafts, Vascular Tagged With: lombardmedical, MicroPort Scientific

Lombard Medical exits U.S. market, shares jump

August 23, 2016 By Brad Perriello

Lombard Medical Technologies (NSDQ:EVAR) said yesterday that it’s bailing out of the U.S. market after an FDA decision requiring a 50-patient clinical study of its Intelliflex low-profile delivery system for the Aorfix stent graft. Lombard said it eliminated its U.S. sales force and moved most of its commercial operations to its U.K. facility, significantly reducing its cash burn. Irvine, […]

Filed Under: Endoscopic, MassDevice Earnings Roundup, Stent Grafts, Wall Street Beat Tagged With: lombardmedical

Lombard expands EU launch of Altura AAA endograft system

July 6, 2016 By Fink Densford

Lombard Medical Technologies (NSDQ:EVAR) said today it expanded the European launch of its Altura endovascular stent graft to the Netherlands and Spain, touting 4 completed procedures with the device in the newly expanded regions. The Altura endograft system is designed as a transcatheter treatment for abdominal aortic aneurysms, and can be repositioned during deployment to allow for […]

Filed Under: Business/Financial News, Vascular Tagged With: lombardmedical

Lombard touts 1st commercial use of IntelliFlex LP with Aorfix stent graft

July 1, 2016 By Fink Densford

Lombard Medical Technologies (NSDQ:EVAR) today touted the 1st commercial use of its IntelliFlex low profile delivery system designed to implant the Aorfix endovascular stent graft in a procedure to treat an abdominal aortic aneurysm. The procedure was performed by Dr. Nilo Mosquera at Spain’s Complexo Hospitalario Universitario de Ourense on the 28th of June, the Irvine, […]

Filed Under: Business/Financial News, Stent Grafts, Surgical Tagged With: lombardmedical

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy